[Amniotic membrane transplantation after surgical resection in conjunctival Kaposi's sarcoma].
OBJECTIVE
To describe a case of isolated conjunctival Kaposi's sarcoma treated with surgical resection and amniotic membrane graft. After surgical resection of the lesion an amniotic membrane graft was used to reconstruct the conjunctival surface. Histological studies were performed.


CONCLUSIONS
Rapid regeneration of the conjunctiva, with minimal scarring, occurred after the surgical procedure and no recurrence of the lesion was observed at 18 months of follow-up. Surgical resection with amniotic membrane grafting appears to be a useful therapeutic option in isolated conjunctival Kaposi's sarcoma.
Rodríguez-Pérez
C
C
Servicio de Oftalmología, Hospital de la Santa Creu i Sant Pau, Universidad Autónoma de Barcelona, Spain. carmen_rp_deruibal@msn.com
Gris-Castellón
O
O
Soler-Lluis
N
N
Del Campo-Carrasco
Z
Z
Wolley-Dod
C
C
D000287:Administration, Topical; D000328:Adult; D000650:Amnion / Q000637:transplantation*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003228:Conjunctiva / Q000502:physiology; D003230:Conjunctival Neoplasms / Q000601:surgery*; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011182:Postoperative Care; D012038:Regeneration / Q000502:physiology; D012514:Sarcoma, Kaposi / Q000601:surgery*; D013997:Time Factors; D014031:Tobramycin / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D003907:Dexamethasone; D014031:Tobramycin